Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 684,705 |
|
|||||
| News | - | ||||||
| Day High | 13.113 | Low High |
|||||
| Day Low | 12.18 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Biomea Fusion Inc | BMEA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.37 | 3.10% | 12.30 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 12.83 | 12.18 | 13.113 | 12.35 | 11.93 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,143 | 684,705 | US$ 12.49 | US$ 8,550,013 | - | 8.125 - 43.69 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:55:46 | 15 | US$ 12.74 | USD |
Biomea Fusion Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 440.25M | 35.71M | - | 0 | -117.26M | -3.28 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Biomea Fusion News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BMEA Price Data
| Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 10.57 | 13.113 | 10.39 | 11.26 | 712,985 | 1.73 | 16.37% |
| 1 Month | 12.61 | 13.66 | 10.22 | 11.74 | 830,953 | -0.31 | -2.46% |
| 3 Months | 18.07 | 19.3549 | 10.22 | 14.96 | 1,042,419 | -5.77 | -31.93% |
| 6 Months | 10.37 | 22.74 | 8.125 | 14.92 | 1,185,525 | 1.93 | 18.61% |
| 1 Year | 29.90 | 43.69 | 8.125 | 18.18 | 906,327 | -17.60 | -58.86% |
| 3 Years | 17.04 | 43.69 | 2.84 | 18.35 | 448,754 | -4.74 | -27.82% |
| 5 Years | 20.00 | 43.69 | 2.84 | 18.35 | 447,898 | -7.70 | -38.50% |
Biomea Fusion Description
| Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. |
